See more : Dottikon Es Holding AG (DESN.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Reliq Health Technologies Inc. (RQHTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reliq Health Technologies Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- InnoTek Limited (M14.SI) Income Statement Analysis – Financial Results
- CCA Industries, Inc. (CAWW) Income Statement Analysis – Financial Results
- Pecos Hotels and Pubs Limited (PECOS.BO) Income Statement Analysis – Financial Results
- Monster Beverage Corporation (MNST) Income Statement Analysis – Financial Results
- Gestamp Automoción, S.A. (GMPUF) Income Statement Analysis – Financial Results
Reliq Health Technologies Inc. (RQHTF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.reliqhealth.com
About Reliq Health Technologies Inc.
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.55M | 1.46M | 1.14M | 181.91K | 2.27M | 182.65K | 536.20K | 31.62K | 29.74K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
Cost of Revenue | 3.25M | 7.26M | 7.52M | 5.84M | 12.24M | 960.12K | 544.48K | 1.85K | 93.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 5.30M | -5.80M | -6.38M | -5.66M | -9.97M | -777.47K | -8.28K | 29.77K | -63.58K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
Gross Profit Ratio | 61.99% | -396.52% | -558.27% | -3,112.71% | -439.17% | -425.65% | -1.54% | 94.15% | -213.83% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
Research & Development | 2.22M | 1.73M | 1.72M | 5.15M | 1.42M | 719.41K | 447.23K | 270.20K | 432.89K | 510.83K | 172.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 10.03M | 10.11M | 8.82M | 7.33M | 12.00M | 1.80M | 1.84M | 4.06M | 331.33K | 517.42K | 398.62K | 812.67K | 769.08K | 663.98K | 44.57K | 0.00 | 0.00 |
Selling & Marketing | 492.65K | 515.70K | 353.48K | 274.48K | 381.68K | 311.50K | 354.60K | 211.65K | 11.24K | 10.30K | 11.67K | 42.26K | 177.38K | 31.29K | 412.00 | 0.00 | 0.00 |
SG&A | 10.52M | 4.10M | 3.06M | 2.64M | 2.40M | 1.30M | 1.97M | 4.27M | 331.33K | 517.42K | 410.29K | 854.94K | 946.46K | 695.27K | 44.98K | 109.46K | 1.00K |
Other Expenses | 888.82K | -5.64K | -58.35K | -34.40K | -32.97K | 189.88K | 18.25K | 0.00 | 0.00 | 0.00 | -2.02K | -3.61K | -28.09K | 1.67K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 13.63M | 5.83M | 4.84M | 7.82M | 3.82M | 2.02M | 2.42M | 4.54M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
Cost & Expenses | 16.88M | 13.09M | 12.37M | 13.67M | 16.06M | 2.98M | 2.96M | 4.55M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
Interest Income | 76.61K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 43.81K | 11.00 | 2.24K | 5.74K | 1.73K | 12.31K | 13.99K | 12.69K | 274.00 |
Interest Expense | 35.28K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 0.00 | 1.17K | 813.00 | 1.11K | 698.00 | 631.00 | 123.00 | 113.00 | 0.00 |
Depreciation & Amortization | 115.29K | 125.76K | 445.41K | 634.16K | 634.16K | 2.05K | 6.17K | 6.17K | 2.18K | 1.49K | 938.00 | 1.94K | 639.00 | 11.28K | 123.00 | 0.00 | 0.00 |
EBITDA | -8.02M | -11.51M | -10.78M | -12.85M | -12.65M | -2.80M | -2.42M | -2.40M | -928.85K | 367.16K | 223.33K | -854.94K | -972.83K | -684.63K | -44.98K | -109.46K | -726.00 |
EBITDA Ratio | -93.79% | -786.98% | -943.01% | -7,064.61% | -607.62% | -1,532.76% | -451.51% | -14,261.37% | 311.96% | 593.03% | 14,918.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
Operating Income | -8.30M | -11.63M | -11.22M | -13.49M | -13.79M | -2.80M | -2.43M | -2.45M | -317.35K | -518.90K | -526.04K | -857.99K | -947.80K | -695.90K | -45.10K | -109.46K | -726.00 |
Operating Income Ratio | -97.01% | -795.58% | -981.98% | -7,413.23% | -607.62% | -1,533.88% | -452.66% | -7,764.22% | -1,067.26% | -838.13% | -35,139.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
Total Other Income/Expenses | 124.77K | -101.19K | 33.51K | 301.31K | -163.28K | 340.54K | -412.46K | -2.10M | -440.25K | -512.27K | -748.97K | 2.13K | -413.04K | -39.36K | 0.00 | 0.00 | 726.00 |
Income Before Tax | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.36M | -735.26K | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 4.00 | 239.11K | 2.00 | -2.05K | 3.00 | 1.00 | -2.02M | 424.09K | 884.57K | 747.99K | -79.38K | -138.88K | -8.98K | -13.99K | 96.88K | 726.00 |
Net Income | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.22M | -735.26K | -31.11K | -96.88K | -726.00 |
Net Income Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
EPS | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
EPS Diluted | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
Weighted Avg Shares Out | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Weighted Avg Shares Out (Dil) | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Reliq Health Technologies, Inc. Announces New Contracts with Three Physician Practices in Puerto Rico, Adding over 3,600 New Patients
Reliq Health Technologies Inc. Announces New Contracts with Three US Physician Practices, Expansion of Texas Medicaid Coverage
Reliq Health Technologies, Inc. to Present at Lytham Partners Fall 2021 Investor Conference
Reliq Health Technologies, Inc. Announces Three New Contracts with Physician Practices in Dallas, TX
Reliq Health Technologies, Inc. to Present at the Virtual Gravitas Health Reimagined Investor Day
Reliq Health Technologies, Inc. Announces New Contract to Provide its iUGO Care Platform to Over 2,500 Cardiology Patients in Puerto Rico
REPEAT -- Reliq Health Technologies, Inc. Announces New Contract to Provide its iUGO Care Platform to Over 1,500 Patients in the US Virgin Islands
Reliq Health Technologies, Inc. Announces New Contract to Provide its iUGO Care Platform to Over 1,500 Patients in the US Virgin Islands
Reliq Health Technologies, Inc. Expands iUGO Care Platform to Support Medicare-Funded RPM, CCM and BHI Services for HIV Patients
Reliq Health Technologies, Inc. Announces New Contracts with Six US Physician Practices
Source: https://incomestatements.info
Category: Stock Reports